Dividend Growth
| Sanofi SA | 27.0% | 17.0% | 13.0% |
|---|---|---|---|
| Roche Holding AG | 22.0% | 14.0% | 6.0% |
| GSK PLC | −44.0% | −44.0% | −44.0% |
| Novartis AG Registered Shares | 31.0% | 14.0% | 8.0% |
| AstraZeneca PLC | 38.0% | 16.0% | 9.0% |
| Novo Nordisk A/S Class B | 214.0% | 80.0% | 65.0% |
| Sanofi SA | 27.0% | 17.0% | 13.0% |
|---|---|---|---|
| Roche Holding AG | 22.0% | 14.0% | 6.0% |
| GSK PLC | −44.0% | −44.0% | −44.0% |
| Novartis AG Registered Shares | 31.0% | 14.0% | 8.0% |
| AstraZeneca PLC | 38.0% | 16.0% | 9.0% |
| Novo Nordisk A/S Class B | 214.0% | 80.0% | 65.0% |